Parisi, O.I.; Ruffo, M.; Malivindi, R.; Vattimo, A.F.; Pezzi, V.; Puoci, F.
Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy. Pharmaceutics 2020, 12, 41.
https://doi.org/10.3390/pharmaceutics12010041
AMA Style
Parisi OI, Ruffo M, Malivindi R, Vattimo AF, Pezzi V, Puoci F.
Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy. Pharmaceutics. 2020; 12(1):41.
https://doi.org/10.3390/pharmaceutics12010041
Chicago/Turabian Style
Parisi, Ortensia Ilaria, Mariarosa Ruffo, Rocco Malivindi, Anna Francesca Vattimo, Vincenzo Pezzi, and Francesco Puoci.
2020. "Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy" Pharmaceutics 12, no. 1: 41.
https://doi.org/10.3390/pharmaceutics12010041
APA Style
Parisi, O. I., Ruffo, M., Malivindi, R., Vattimo, A. F., Pezzi, V., & Puoci, F.
(2020). Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy. Pharmaceutics, 12(1), 41.
https://doi.org/10.3390/pharmaceutics12010041